期刊文献+

子宫内膜癌166例临床分析 被引量:2

Clinical analysis of prognostic factors in 166 cases with endometrial carcinoma
原文传递
导出
摘要 目的 探讨与子宫内膜癌预后相关的临床、病理因素.方法 回顾性分析汕头大学附属肿瘤医院妇瘤科1996年5月至2009年6月收治的166例子宫内膜癌患者临床资料,并随访患者生存情况,进行生存及预后分析.结果 166例子宫内膜癌患者5年总生存率86.7%,单因素分析示年龄、子宫肌层的受侵程度、淋巴结转移和手术-病理分期与预后相关(P<0.05),多因素分析发现年龄、子宫肌层的受侵程度和淋巴结转移与预后有关(P<0.05).结论 子宫内膜癌患者总生存率高,手术-病理分期很好地提示了患者的预后,年龄、肌层受侵程度和淋巴结转移可能是影响子宫内膜癌预后的重要因素。 Objective To explore the prognostic factors of endometrial carcinoma.Methods 166 patients with endometrial carcinoma in Cancer Hospital of Shantou University Medical College from May 1996 to June 2009 were analyzed retrospectively.Prognostic factors were analyzed by univariate analysis.Results The total 5-year survival rate of 166 cases was 86.7 %.The univariate analysis showed that the age,deep myometrial invasion,lymph-node metastasis and operative-pathological staging were significantly associated with the prognosis (P 〈 0.05).As well as,according to muhivariate Cox proportional-hazard model,3 independent factors as the age,deep myometrial invasion and lymph-node metastasis were related significantly to overall survival (P 〈 0.05).Conclusions The 5-year survival rate of endometrial carcinoma is high.The age,deep myometrial invasion and lymph-node metastasis are independent prognostic factors of endometrial carcinoma.
出处 《肿瘤研究与临床》 CAS 2015年第8期529-531,534,共4页 Cancer Research and Clinic
基金 广东省科技计划资助项目(20118031800367)
关键词 子宫内膜肿瘤 年龄 淋巴转移 预后 Endometrial neoplasm Age Lymphatic metastasis Prognosis
  • 相关文献

参考文献10

二级参考文献46

  • 1王骅,王志瑾.影响子宫内膜癌手术治疗预后因素的COX模型分析[J].癌症,1996,15(4):290-292. 被引量:3
  • 2王志启,王建六,赵丹,高敏,魏丽惠.晚期子宫内膜癌患者预后及其相关因素分析[J].实用妇产科杂志,2007,23(1):39-42. 被引量:7
  • 3Creasman WT, Odicino F, Maisonneuve P,et al. Carcinoma of the corpus uteri. FIGO 6th Annual Report on the Results of Treatment in Gynecological Cancer. Int J Gynaecol Obstet, 2006,95 : 105- 143. 被引量:1
  • 4Smith RS, Kapp DS, Chen Q, et al. Treatment of high-risk uterine cancer with whole abdominopelvic radiation therapy. Int J Radiat Oncol Biol Phys ,2000 ,48:767-778. 被引量:1
  • 5Randall ME, Filiaci VL, Muss H, et al. Randomized phase Ⅲ trial of whole-abdominal irradiation versus doxorubicin and cisplatin chemotherapy in advanced endometrial carcinoma: a Gynecologic Oncology Group Study. J Clin Oncol,2006,24:36-44. 被引量:1
  • 6Schorge JO, Molpus KL, Goodman A, et al. The effect of postsurgical therapy on stage Ⅲ endometrial carcinoma. Gynecol Oncol, 1996,63 : 34 -39. 被引量:1
  • 7Aoki Y, Kase H, Watanabe M, et al. Stage Ⅲ endometrial cancer: analysis of prognostic factors and failure patterns after adjuvant chemotherapy. Gynecol Oncol,2001,83 : 1-5. 被引量:1
  • 8Goff BA, Goodman A, Muntz HG, et al. Surgical stage Ⅳ endometrial carcinoma: a study of 47 cases. Gynecol Oncol,1994, 52:237-240. 被引量:1
  • 9Bristow RE, Zerbe MJ, Rosenshein NB, et al. Stage IVB endometrial carcinoma: the role of cytoreductive surgery and determinants of survival. Gynecol Oncol,2000 ,78 :85-91. 被引量:1
  • 10Mikuta JJ. International Federation of Gynecology and Obstetrics staging of endometrial cancer 1988. Cancer,1993,71:1460-1463. 被引量:1

共引文献51

同被引文献17

引证文献2

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部